Extrapyramidal System/Symptoms/Signs Should Be Retired.
Journal
Neurology. Clinical practice
ISSN: 2163-0402
Titre abrégé: Neurol Clin Pract
Pays: United States
ID NLM: 101577149
Informations de publication
Date de publication:
Aug 2024
Aug 2024
Historique:
received:
05
01
2024
accepted:
14
02
2024
pmc-release:
01
08
2025
medline:
29
5
2024
pubmed:
29
5
2024
entrez:
29
5
2024
Statut:
ppublish
Résumé
The term "extrapyramidal system/symptoms/signs" and the acronym "EPS" have been abundantly used in neurology and psychiatry literature for more than a century. However, EPS has been increasingly criticized, especially by movement disorder neurologists, for its lack of clinical, anatomical, and physiologic definition. Contrary to traditional assumptions, pyramidal and extrapyramidal systems are not mutually exclusive. The acronym EPS, commonly used to denote drug-induced movement disorders, lacks specificity in conveying the nature and severity of these and other movement disorders. Consequently, we propose that the term is retired from scientific literature and that clinicians use specific phenomenologic descriptors for the various hypokinetc and hyperkinetic movement disorders.
Identifiants
pubmed: 38808022
doi: 10.1212/CPJ.0000000000200308
pii: CPJ-2023-000708
pmc: PMC11129327
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e200308Informations de copyright
© 2024 American Academy of Neurology.
Déclaration de conflit d'intérêts
The authors report no relevant disclosures. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.